Home » Portfolio » Alnara Pharmaceuticals (acq. by Eli Lilly)
Alnara Pharmaceuticals (acq. by Eli Lilly)
Investment Year
2008
Exit
2010
Sector
Geography
North America - East
Website
www.alnara.com

Alnara Pharmaceuticals (acq. by Eli Lilly)

Develops non-systemic, protein therapeutics to treat metabolic and inflammatory diseases. In 2010 it was acquired by Eli Lilly and Company (NYSE:LLY).

Team

Christopher Gabrieli Christopher Gabrieli Stephen Kraus Stephen Kraus